Should You Buy UPS Stock While It's Below $90?

United Parcel Service (UPS) reported Q2 2025 revenue down 2.7% and adjusted EPS down 13.4% amid macroeconomic uncertainty, including tariff impacts on key trade lanes and weak consumer sentiment, contributing to a significant stock decline. Despite these challenges, UPS is implementing a strategic shift, reducing low-margin Amazon volumes by over 50% by 2026, targeting $3.5 billion in FY2025 expense cuts, and expanding into higher-margin healthcare logistics. Trading at a forward P/E of 11.2 and offering a 7.8% dividend yield with management commitment, the stock presents a potential value or income opportunity for investors, despite lingering uncertainties.

Analysis

United Parcel Service (UPS) is navigating a period of significant operational and financial headwinds, reflected in its Q2 2025 results which saw a 2.7% year-over-year revenue decline and a 13.4% drop in adjusted diluted EPS. The primary drivers of this weakness are external: pervasive macroeconomic uncertainty, which has led management to withdraw forward guidance, and specific trade policy impacts. U.S. tariffs have precipitated a roughly 35% decline in volume on the company's most profitable China-U.S. shipping lane, while weak consumer sentiment and manufacturing activity in the U.S. add further pressure. In response, management is executing a strategic pivot designed to enhance profitability. This includes a deliberate reduction of low-margin Amazon volumes by over 50% by 2026, a move contributing to a targeted $3.5 billion in expense cuts for full-year 2025. Concurrently, UPS is reallocating resources toward higher-margin verticals, notably complex healthcare logistics, a market with an $82 billion total addressable size, supported by its planned acquisition of Andlauer Healthcare Group. Despite the stock's significant decline, the company's valuation appears attractive at a forward P/E of 11.2, and it offers a substantial 7.8% forward dividend yield, which management has publicly committed to maintaining and growing.

Key Decisions for Investors

• Value and income-focused investors may find the current valuation attractive, given the low 11.2 forward P/E and a 7.8% dividend yield backed by management's commitment, but the stock is unsuitable for those prioritizing near-term growth.
• Investors should closely monitor the execution of the company's strategic pivot, specifically tracking profit margin improvements as it sheds low-margin Amazon business and expands its higher-margin healthcare logistics segment.
• It is crucial to weigh the potential for a long-term turnaround against significant external risks, including continued macroeconomic weakness and trade policy uncertainty, which could delay the strategic initiatives from translating into bottom-line growth.
• While the dividend appears secure based on management commentary, investors should scrutinize cash flow and earnings reports for any signs of stress that could challenge the sustainability of the payout in a prolonged downturn.